ARSUF: Fagron NV Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,354.04
Enterprise Value ($M) n/a
Book Value ($M) 505.36
Book Value / Share 6.94
Price / Book n/a
NCAV ($M) -215.60
NCAV / Share -2.96
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.17

Liquidity (mrq)
Quick Ratio 1.16
Current Ratio 1.86

Balance Sheet (mrq) ($M)
Current Assets 362.56
Assets 1,083.52
Liabilities 578.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 871.96
Operating Income 130.70
Net Income 80.55

Cash Flow Statement (mra) ($M)
Cash From Operations 109.89
Cash from Investing -69.74
Cash from Financing -54.01

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
ARDS – Aridis Pharmaceuticals, Inc. ARGNF – argenx SE
ARNI – Arno Therapeutics, Inc. ATHXQ – Athersys, Inc.
ATRX – Adhera Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io